Linschoten
Netherlands
57
2022-04-14
The entities that hold a legal rights for patent applications filed by inventor VOGELS Ronald:
Ronald VOGELS from Linschoten, NL has applied for patents for these inventions. The list has both pending applications and granted patents:
Methods and compositions for heterologous repRNA immunizations
#2 | 2021-11-11RNA Replicon Encoding a Stabilized Corona Virus Spike Protein
#3 | 2021-11-11SARS-CoV-2 Vaccines
#4 | 2020-09-24Binding molecules directed against influenza hemagglutinin and uses thereof
#5 | 2020-07-23Methods and compositions for heterologous repRNA immunizations
#6 | 2020-05-07Structure based design of d-protein ligands
#7 | 2019-11-28Binding molecules directed against influenza hemagglutinin and uses thereof
#8 | 2018-01-18Binding molecules directed against influenza hemagglutinin and uses thereof
#9 | 2016-12-15Influenza virus vaccines and uses thereof
#10 | 2016-12-08INFLUENZA VIRUS VACCINES AND USES THEREOF
#11 | 2016-01-07HUMAN BINDING MOLECULES CAPABLE OF BINDING TO AND NEUTRALIZING INFLUENZA B VIRUSES AND USES THEREOF
#12 | 2015-10-01Human binding molecules capable of neutralizing influenza A viruses of phylogenetic group 1 and phylogenetic group 2 and influenza B viruses
#13 | 2015-02-05Human binding molecules capable of binding to and neutralizing influenza B viruses and uses thereof
#14 | 2015-01-08Complementing cell lines
#15 | 2014-12-04Influenza virus vaccines and uses thereof
#16 | 2014-11-20Human binding molecules capable of binding to and neutralizing influenza B viruses and uses thereof
#17 | 2014-05-01Human binding molecules capable of neutralizing influenza A viruses of phylogenetic group 1 and phylogenetic group 2 and influenza B viruses
#18 | 2014-03-06Human binding molecules capable of binding to and neutralizing influenza B viruses and uses thereof
#19 | 2013-09-19Human binding molecules capable of binding to and neutralizing influenza B viruses and uses thereof
#20 | 2013-06-20COMPLEMENTING CELL LINES
#21 | 2011-12-22Settings for recombinant adenoviral-based vaccines
#22 | 2011-11-17Multivalent vaccines comprising recombinant viral vectors
#23 | 2011-10-20Multivalent vaccines comprising recombinant viral vectors
#24 | 2010-12-09Packaging cells for recombinant adenovirus
#25 | 2010-02-11Serotype of adenovirus and uses thereof
#26 | 2010-01-21Settings for recombinant adenoviral-based vaccines
#27 | 2009-10-08Gene delivery vectors provided with a tissue tropism for smooth muscle cells, and/or endothelial cells
#28 | 2009-05-14Multivalent vaccines comprising recombinant viral vectors
#29 | 2008-08-28Stable adenoviral vectors and methods for propagation thereof
#30 | 2008-08-21Means and methods for producing adenovirus vectors
#31 | 2008-08-21Complementing cell lines
#32 | 2008-07-17Serotype of adenovirus and uses thereof
#33 | 2008-06-26Settings for recombinant adenoviral-based vaccines
#34 | 2008-05-15Transient protein expression methods
#35 | 2007-07-31Complementing cell lines
#36 | 2007-07-03Means and methods for fibroblast-like or macrophage-like cell transduction
#37 | 2007-02-22Serotype of adenovirus and uses thereof
#38 | 2006-08-17Packaging cells for recombinant adenovirus
#39 | 2006-04-18High throughput screening of gene function using libraries for functional genomics applications
#40 | 2006-01-19Chimeric adenoviruses
#41 | 2005-12-15Complementing cell lines
#42 | 2005-12-13Complementing cell lines
#43 | 2005-10-20Serotype of adenovirus and uses thereof
#44 | 2005-10-06Recombinant virus production for the manufacturing of vaccines
#45 | 2005-09-08Settings for recombinant adenoviral-based vaccines
#46 | 2005-08-18Gene delivery vectors with cell type specificity for mesenchymal stem cells
#47 | 2005-08-16Gene delivery vectors provided with a tissue tropism for smooth muscle cells, and/or endothelial cells
#48 | 2005-08-04Gene delivery vectors provided with a tissue tropism for smooth muscle cells, and/or endothelial cells
#49 | 2005-07-28Stable adenoviral vectors and methods for propagation thereof
#50 | 2005-07-21Means and methods for the production of adenovirus vectors
#51 | 2005-07-05Serotype of adenovirus and uses thereof
#52 | 2005-06-14Gene delivery vectors with cell type specificity for mesenchymal stem cells
#53 | 2005-04-21Serotype of adenovirus and uses thereof
#54 | 2005-04-12Packaging systems for human recombinant adenovirus to be used in gene therapy
#55 | 2005-04-07Packaging systems for human recombinant adenovirus to be used in gene therapy
#56 | 2005-03-22Complementing cell lines
#57 | 2005-03-22Means and methods for fibroblast-like or macrophage-like cell transduction
298592 ⎘